Welcome to our dedicated page for Acacia Resh SEC filings (Ticker: ACTG), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Acacia Research Corporation filings document the company’s public reporting as an acquirer and operator of businesses in industrial, energy and technology sectors. Form 8-K reports furnish operating and financial results, segment reporting and material-event disclosures, including capital-structure and governance matters.
Proxy materials for ACTG address board elections, committee matters, executive compensation and shareholder voting items. Other current reports record leadership and board composition changes, while earnings-related exhibits describe the company’s operating segments, including Benchmark, Printronix, Deflecto and Acacia Research Group.
Acacia Research Corporation files its Annual Report describing a diversified, acquisition-driven model spanning intellectual property, energy, industrial and manufacturing businesses. The company partners closely with controlling shareholder Starboard Value to source complex, often undervalued assets.
Acacia’s IP unit has executed over 1,600 license agreements and generated about $1.9 billion in gross licensing revenue since inception. The Energy Operations Business now owns roughly 73.5% of Benchmark Energy II, which acquired Anadarko Basin assets for $145 million and produced 2,081 Mboe in 2025.
Industrial and manufacturing operations include Printronix and Deflecto, the latter acquired for $103.7 million. Acacia has also largely monetized its Life Sciences Portfolio, receiving $564.1 million in proceeds through December 31, 2025. The filing highlights extensive risk factors around acquisition execution, integration, commodity exposure, regulation and dependence on key personnel and Starboard.
Acacia Research Corporation reported strong fourth quarter and full-year 2025 results, highlighted by record annual revenue of $285.2 million, up 133% from $122.3 million in 2024. Growth was driven by a full year of Manufacturing Operations and higher Energy and Intellectual Property revenue.
For Q4 2025, Acacia generated revenue of $50.1 million, GAAP net income of $3.4 million (diluted EPS of $0.04) and Adjusted Net Income of $3.1 million (Adjusted diluted EPS of $0.03). Total Company Adjusted EBITDA was $17.4 million, and Operated Segment Adjusted EBITDA was $22.4 million for the quarter.
For the full year 2025, GAAP net income reached $21.7 million (diluted EPS of $0.22), with Adjusted Net Income of $29.2 million (Adjusted diluted EPS of $0.30). Total Company Adjusted EBITDA rose to $77.9 million and Operated Segment Adjusted EBITDA to $96.4 million, both sharply higher than 2024. Year-end cash, cash equivalents, equity securities measured at fair value and loans receivable totaled $339.6 million, or $3.52 per share, supporting a book value per share of $6.05.
Acacia Research Corporation reported that board member Geoff Ribar has informed the company he will not stand for reelection at the 2026 Annual Meeting of Stockholders. He currently serves as chairman of the Board’s Nominating, Governance and Sustainability Committee and is a member of the Audit Committee.
The company states that Mr. Ribar’s decision, which he attributed to personal reasons including his time commitments to other boards, is not based on any disagreement with Acacia or its Board regarding operations, policies, or practices.
Acacia Research (ACTG) reported Q3 results showing higher revenue and narrower losses while integrating recent acquisitions across energy, industrial, and manufacturing operations.
Total revenue was $59.4 million, up from $23.3 million a year ago, led by manufacturing ($30.8 million) from the Deflecto business and stronger intellectual property licensing ($7.8 million, driven by paid-up licenses). Energy contributed $14.2 million and industrial $6.7 million. Operating loss improved to $6.4 million from $10.3 million, and net loss attributable to Acacia narrowed to $2.7 million, or $0.03 per share, from $14.0 million, or $0.14 per share.
For the nine months, revenue reached $235.1 million versus $73.5 million, with operating income of $19.5 million and net income of $18.3 million. Cash and cash equivalents were $301.8 million as of September 30, 2025. Benchmark’s revolving credit facility balance was $58.5 million and the Deflecto facility was $35.5 million. Shares outstanding were 96,460,378 as of September 30, 2025.
Acacia Research Corporation furnished a press release announcing its financial results for the quarter ended September 30, 2025. The release was provided under Item 2.02 and is attached as Exhibit 99.1. The company notes this information is being furnished and is not deemed “filed” under Section 18 of the Exchange Act, and it will not be incorporated by reference into Securities Act filings unless specifically referenced.
Exhibits include: 99.1 (Press Release dated November 5, 2025) and 104 (Cover Page Interactive Data File).
Gavin T. Molinelli, a director of Acacia Research Corp (ACTG), received 9,231 shares of the company's common stock on 09/30/2025 as payment in lieu of cash for director fees for Q3 2025. The shares were issued at a price of $3.25 per share. After the grant, Mr. Molinelli beneficially owned 160,218 shares of Acacia Research Corp.
The Form 4 was signed by Mr. Molinelli on 10/01/2025 and reports a routine, non-derivative acquisition of equity tied to director compensation. The filing shows direct ownership and does not report any derivative transactions.
Zambito Michael SIKORYAK, identified on the filing as the issuer's Chief Financial Officer, reported a purchase of 7,700 shares of Acacia Research Corporation (ACTG) on 08/11/2025. The transaction was coded P for a purchase and was executed at a weighted average price of $3.2658, with the filing noting component trades priced between $3.25 and $3.32. Following the transaction the reporting person beneficially owned 7,700 shares in a direct capacity.
The Form 4 was signed by an attorney-in-fact, Jennifer Graff, on 08/12/2025. No derivative transactions or other securities classes are reported on this filing, and no amendments or additional material items are included.
Michelle Felman, identified as a director of Acacia Research Corporation (ACTG), reported two gift transactions of company common stock dated 08/11/2025. The filing states she gifted 11,560 shares and 11,561 shares to an irrevocable trust established for the benefit of her son, and that each gift was for no consideration.
The Form 4 shows the transactions coded as gifts and reports post-transaction direct beneficial ownership figures of 43,733 shares and 32,172 shares respectively as listed on the form. The filing is signed by an attorney-in-fact.